Document 0076 DOCN M9440076 TI Efficacy of CHOP and G-CSF combination treatment versus CHOP monotherapy in HIV-1 infected patient with NHL (Meeting abstract). DT 9404 AU Gori A; Ridolfo AL; Romaniello A; Franzetti F; Coppin P; Formenti T; Gervasoni C; d'Arminio Monforte A; Moroni M; Clinic of Infectious Diseases, Univ. of Milan, Italy SO Biological Response Modifiers, 2nd International Congress. January 29-31. 1993, San Diego, CA, p. 76, 1993.. Unique Identifier : AIDSLINE ICDB/94698348 AB Objective: To evaluate whether G-CSF and CHOP treatment in HIV-1 infected patients with high-grade NHL allows a better adherence to the therapeutic schedule as compared to patients treated with CHOP alone. Methods: We evaluated retrospectively 6 patients treated with CHOP compared with 8 patients treated with CHOP associated with G-CSF (5 g/kg/day sc from 8th to 21st day of each cycle). In each group, we evaluated the number of cycles, the pauses between cycles, the necessity of drug dosage reduction, the degree of leukopenia at nadir, the duration of neutropenia (ANC less than 1000/mm3), the days of fever and the number of infectious episodes. Results are presented in a table. Conclusions: These preliminary data show that the patients treated with the association of G-CSF and chemotherapy withstand a greater number of cycles of therapy, at full doses and regular pauses, experiencing a reduction of the days of neutropenia, fever and infectious episodes. DE Antineoplastic Agents, Combined/ADVERSE EFFECTS/*THERAPEUTIC USE Cyclophosphamide/ADMINISTRATION & DOSAGE Doxorubicin/ADMINISTRATION & DOSAGE Fever/CHEMICALLY INDUCED/DRUG THERAPY Granulocyte Colony-Stimulating Factor/*THERAPEUTIC USE HIV Infections/COMPLICATIONS/*DRUG THERAPY Human Leukopenia/CHEMICALLY INDUCED/DRUG THERAPY Lymphoma, Non-Hodgkin's/COMPLICATIONS/*DRUG THERAPY Neutropenia/CHEMICALLY INDUCED/DRUG THERAPY Prednisone/ADMINISTRATION & DOSAGE Vincristine/ADMINISTRATION & DOSAGE MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).